Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands		Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total	Temporary Equity [Member] Convertible Preferred Stock [Member]
Balance at Dec. 31, 2024		$ 3	$ 1	$ 111,509	$ 44	$ (128,070)	$ (16,513)
Balance, shares at Dec. 31, 2024		26,560,266	2,963,695
Stock based compensation related to options granted to employees and non-employees				82			82
Exercise of options and vesting of early exercise
Balance, shares			609
Foreign currency translation adjustments, net of tax					(17)		(17)
Net income (loss)						(2,162)	(2,162)
Issuance of Series CF preferred stock				2,476			2,476
Balance, shares		1,033,601
Balance at Mar. 31, 2025		$ 3	$ 1	114,067	27	(130,232)	(16,134)
Balance, shares at Mar. 31, 2025		27,593,867	2,964,304
Balance at Dec. 31, 2025		$ 2	$ 1	116,556	(70)	(139,152)	(22,663)	$ 11,389
Balance, shares at Dec. 31, 2025		17,494,820	13,896,400					1,237,717
Stock based compensation related to options granted to employees and non-employees				203			203
Exercise of options and vesting of early exercise	[1]
Balance, shares			96
Issuance of common shares for service				2,035			2,035
Issuance of common shares for service, shares			161,963
Issuance of common shares related to direct listing
Issuance of common shares related to direct listing, shares			418,219
Exercise of Common Warrants to Common Stock				20			20
Exercise of Common Warrants to Common Stock, shares			4,479
Issuance of Series D convertible preferred stock- net of issuance costs								$ 2,679
Balance, shares								324,175
Conversion of Series E Preferred Stock into Common Stock			$ 1	6,828			6,829	$ (6,828)
Balance, shares			1,477,857					(682,770)
Exercise of Series D Common Warrants into Common Stock - net of issuance costs				93			93
Exercise of Series D Common Warrants into Common Stock - net of issuance costs, shares			8,098
Conversion of Series D Convertible Preferred Stock into Common Stock				196			196	$ (196)
Balance, shares			19,433					(24,000)
Exercise of Series C Common Warrants into Common Stock - net of issuance costs				3,121			3,121
Exercise of Series C Common Warrants into Common Stock - net of issuance costs, shares			1,033,335
Conversion of Series C Convertible Preferred Stock into Common Stock				2,309			2,309	$ (2,309)
Balance, shares			1,367,742					(277,171)
Conversion of B-2 Preferred Stock into Common Stock
Balance, shares		(607,775)	607,775
Conversion of B-3 Preferred Stock into Common Stock
Balance, shares		(2,057,103)	2,057,102
Common Stock Dividend				85		(85)
Balance, shares			22,109
Direct Listing Costs				(250)			(250)
Cash Dividend						(136)	(136)
Foreign currency translation adjustments, net of tax					(27)		(27)
Net income (loss)						(6,703)	(6,703)
Balance at Mar. 31, 2026		$ 2	$ 2	$ 131,196	$ (97)	$ (146,076)	$ (14,973)	$ 4,735
Balance, shares at Mar. 31, 2026		14,829,942	21,074,608					577,951

[1] )Represents less than $1